PDCO Stock Gains on the News of Acquisition Deal With Patient Square

Zacks12-16

Patterson Companies PDCO recently announced that it has entered into a definitive agreement to be acquired by Patient Square Capital (Patient Square), a dedicated healthcare investment firm. Patterson...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2491694970?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/X_G78K7TS0Wks9k_NbYhwg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644","is_english":true,"pubTime":"2024-12-16 20:55","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2491694970","market":"us","top_or_hot":-1,"title":"PDCO Stock Gains on the News of Acquisition Deal With Patient Square","media":"Zacks","content":"<div>\n<p>Patterson Companies PDCO recently announced that it has entered into a definitive agreement to be acquired by Patient Square Capital (Patient Square), a dedicated healthcare investment firm.\nPatterson...</p>\n\n<a href=\"https://finance.yahoo.com/news/pdco-stock-gains-news-acquisition-125500783.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PDCO Stock Gains on the News of Acquisition Deal With Patient Square</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPDCO Stock Gains on the News of Acquisition Deal With Patient Square\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-16 20:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pdco-stock-gains-news-acquisition-125500783.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Patterson Companies PDCO recently announced that it has entered into a definitive agreement to be acquired by Patient Square Capital (Patient Square), a dedicated healthcare investment firm.\nPatterson...</p>\n\n<a href=\"https://finance.yahoo.com/news/pdco-stock-gains-news-acquisition-125500783.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ANGO","symbol_name":"阿吉奥动态","start_time":0,"source_url":"https://finance.yahoo.com/news/pdco-stock-gains-news-acquisition-125500783.html","article_id":"2491694970","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/X_G78K7TS0Wks9k_NbYhwg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2491694970","pubTimestamp":1734353700,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Patterson CompaniesPDCO recently announced that it has entered into a definitive agreement to be acquired by Patient Square Capital , a dedicated healthcare investment firm.Patterson’s shareholders will receive $31.35 in cash per share per the acquisition agreement with Patient Square, indicating a 49% premium over its 30-day volume-weighted average price as of Dec. 4, 2024. The total transaction is valued at approximately $4.1 billion, including the refinancing of Patterson’s receivables facilities.Once the acquisition is completed, Patterson, which connects dental and animal health customers with a wide range of products and services, will become a privately held company. This transaction is expected to be closed in the fourth quarter of fiscal 2025, subject to the receipt of its shareholder approval, regulatory approvals and the satisfaction of other customary closing conditions.Following the announcement, shares of the company surged 34.5% and closed at $31.08 on Friday. In the yea","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ANGO":"阿吉奥动态","LU2764262908.HKD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (HKD) ACC","GMED":"Globus Medical Inc","PDCO":"帕特森","BK4082":"医疗保健设备","LU2764263039.SGD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (SGDHDG) ACC","LU2720916845.USD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (USD) ACC","BK4567":"ESG概念","LU2065732104.USD":"ALLSPRING (LUX) WF GLOBAL SMALL CAP EQUITY \"I\" (USD) ACC","LU2764263203.CNY":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (CNYHDG) ACC","LU0205193047.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","LU0205194284.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD) INC AV","MASI":"麦斯莫医疗","LU0240878834.USD":"SCHRODER ISF GLOBAL SMALL COMPANIES \"A\" (USD) INC AV","IE0009354923.USD":"JANUS HENDERSON US VENTURE \"A2\" (USD) ACC","BK4175":"保健护理产品经销商","LU0240877869.USD":"SCHRODER ISF GLOBAL SMALL COMPANIES \"A\" ACC"},"translate_title":"PDCO股价因与Patient Square收购交易的消息而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PDCO":1,"MASI":1,"GMED":1,"ANGO":1},"content_text":"Patterson Companies PDCO recently announced that it has entered into a definitive agreement to be acquired by Patient Square Capital (Patient Square), a dedicated healthcare investment firm.\nPatterson’s shareholders will receive $31.35 in cash per share per the acquisition agreement with Patient Square, indicating a 49% premium over its 30-day volume-weighted average price as of Dec. 4, 2024. The total transaction is valued at approximately $4.1 billion, including the refinancing of Patterson’s receivables facilities.\nOnce the acquisition is completed, Patterson, which connects dental and animal health customers with a wide range of products and services, will become a privately held company. This transaction is expected to be closed in the fourth quarter of fiscal 2025, subject to the receipt of its shareholder approval, regulatory approvals and the satisfaction of other customary closing conditions.\nLikely Trend of PDCO Stock Following the News\nFollowing the announcement, shares of the company surged 34.5% and closed at $31.08 on Friday. In the year-to-date period, PDCO’s shares have gained 9.3% compared with the industry’s 2.5% growth. The S&P 500 increased 27.8% in the same time frame.\nMeanwhile, PDCO currently has a market capitalization of $2.74 billion.\nImage Source: Zacks Investment Research\nMore on PDCO’s Acquisition Deal With Patient Square\nPatient Square is a dedicated healthcare investment firm with approximately $11 billion in assets under management as of Sept. 30, 2024. The firm aims to achieve strong investment returns by partnering with growth-oriented companies and top-tier management teams whose products, services and technologies improve health.\nThe merger agreement includes a 40-day “go-shop” period that permits the Patterson board and its advisors to actively solicit alternative acquisition proposals from third parties.\nRecent Quarterly Performance of PDCO\nPatterson Companies delivered an adjusted earnings per share of 47 cents in the second quarter of fiscal 2025, down 6% year over year. Its registered revenues improved 1.3% year over year to  $1.67 billion.\nIn the last reported quarter, the Dental segment of PDCO reported revenues of $611.7 million, down 2.3% from the year-ago quarter. Revenues in the Animal Health segment totaled $1.05 billion, up 2.9% year over year on a reported basis.\nPDCO’s Recent Developments\nIn November, Patterson Dental Supply, Inc., a subsidiary of PDCO, announced an agreement in principle between Patterson and PDS Health, a leading dental and medical support organization, to extend their strategic relationship through the end of 2027. This extension allows Patterson to continue as the premier distributor for all merchandise, services, technology and core equipment across PDS Health’s network of more than 1,000 supported practices nationwide.\nPDCO’s Zacks Rank & Stocks to Consider\nPDCO carries a Zacks Rank #4 (Sell) at present.\nSome better-ranked stocks from the medical industry are Masimo MASI, AngioDynamics ANGO and Globus Medical GMED.\nMasimo, sporting a Zacks Rank #1 (Strong Buy) at present, has an estimated growth rate of 10.4% for 2025. You can see the complete list of today’s Zacks #1 Rank stocks here.\nMASI’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 17.10%. Masimo’s shares have risen 37.2% year to date compared with the industry’s 6.7% growth.\nAngioDynamics, carrying a Zacks Rank #2 (Buy) at present, has an estimated growth rate of 38.2% for 2025. ANGO’s earnings surpassed estimates in three of the trailing four quarters and missed once, delivering an average surprise of 31.71%.\nAngioDynamics’ shares have lost 8.9% year to date against the industry’s 6.7% growth.\nGlobus Medical, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 12.7%. GMED’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 12.1%. Its shares have risen 56.5% year to date compared with the industry’s 6.7% growth.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nAngioDynamics, Inc. (ANGO) : Free Stock Analysis Report\nMasimo Corporation (MASI) : Free Stock Analysis Report\nPatterson Companies, Inc. (PDCO) : Free Stock Analysis Report\nGlobus Medical, Inc. (GMED) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2491694970"}